Emphasis on Drug Type (Antidepressants, Anticonvulsants, Atypical Antipsychotics, Benzodiazepines, and Beta-blockers); Distribution Channels (Hospital Pharmacies, Retail Pharmacies, and Online Channels); Disorder Type (Major Depressive Disorder (MDD), OCD, Phobia, PTSD, and Others); Region/Country
The global anxiety and depression treatment market is anticipated to grow with an elevated CAGR of around 3% over the forecast period (2021-2027). Anxiety and Depression are the most common mental disorders where the melancholy mood lasts for a long duration. Thus, affects the overall efficiency of the person, and depression is directly linked with stress and anxiety. The long term anxiety is considered one of the symptoms of depression.
The rapidly developing novel drugs and rising awareness about the severity of mental disorders among people contribute to the significant market growth of the anxiety and depression treatment market. The changing lifestyle preferences such as consumption of the substance and problems like insomnia are the major factors contributing to the increasing number of depression cases. Moreover, the increasing unemployment around the globe is also responsible for the increasing stress and anxiety levels among the youths resulting in the increasing demand for better treatment of anxiety and depression. As per the international labor organization, the global unemployment rate is increasing by 6.7% annually.
GlaxoSmithKline plc, Pfizer, Inc., Eli Lilly and Company, H. Lundbeck A/S, Forest Laboratories, Inc., AstraZeneca, Merck & Company, Inc., Johnson & Johnson, and Sanofi-Aventis are some of the prominent players operating in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with new varieties of anxiety and depression treatments.
Insights Presented in the Report
“Amongst Drug Type, anti-depressant drug segment holds the major share”
Based on drug types, the anxiety and depression treatment market is segmented into antidepressants, anticonvulsants, atypical antipsychotics, benzodiazepines, and Beta-blockers. The anti-depressant drug class is expected to have significant growth during the forecast period owing to the continuous development and approval of the new medications for the treatment of anxiety and depression. For instance, in April 2022, Lupin Ltd received approval from the US health regulator to market its generic version of Desvenlafaxine extended-release tablets used for treating depression.
“Amongst distribution channels, online channel segment holds the major share”
Based on the distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online channels. Amongst them, the online pharmacies distribution channel is expected to witness significant growth due to the rising investment in e-pharmacy across the world. However, anxiety and depression drugs are mostly available only through prescription. Thus, doctors are now preferring e-prescriptions to allow patients to get easy access to medicine with the help of e-prescriptions. Countries, like the United Kingdom, are putting more effort into the implementation of e-prescriptions. For instance, the electronic prescription service (EPS) will be rolled out across England after a trial run in 60 GP practices and hundreds of pharmacies, in 2019. National Health Service (NHS) aimed to save USD 373 million in the next two years.
Amongst disorder types, the major depressive disorder segment holds the major share”
Based on the disorder type, the market is segmented into major depressive disorder (MDD), OCD, phobia, PTSD, and others. Among them, the market for major depressive disorder is expected to witness significant growth. The growth of the segmented is mainly attributed to the increasing level of workplace stress and the number of suffering people along with a lack of the appropriate knowledge about the severity of the diseases leads to the development of stress into major depressive disorder. According to the American workplace and NIOSH Reports, 80% of workers feel stress on the job among them 40% of workers reported their job was very or extremely stressful.
“North America represents one of the largest markets of Anxiety and Depression Treatment market”
For a better understanding of the market dynamics of the Anxiety and Depression Treatment market, a detailed analysis was conducted for different regions across the globe including North America (U.S, Canada, and the Rest of North America), Europe (Germany, France, Spain, United Kingdom, Italy, and Rest of Europe), Asia-Pacific (China, India, Australia, Japan, and Rest of APAC), Rest of World has been conducted. In 2020, North America accounted for the majority share in the market. The increasing number of awareness programs by the governments is driving the market for anxiety and depression disorders in the region. Canada, for instance, launched the mental illness awareness week in October 2021 to educate people about mental health and its effects.
Reasons to buy this report:
Customization Options:
The global anxiety and depression treatment market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
1. Market Introduction
2. Research Methodology Or Assumption
3. Market Synopsis
4. Executive Summary
5. Global Anxiety And Depression Treatment Market Covid-19 Impact
6. Global Anxiety And Depression Treatment Market Revenue, 2019-2027f
7. Market Insights By Drug Type
8. Market Insights By Distribution Channel
9. Market Insights By Disorder Type
10. Market Insights By Region
11. Anxiety And Depression Treatment Market Dynamics
12. Anxiety And Depression Treatment Market Opportunities
13. Anxiety And Depression Treatment Market Trends
14. Legal & Regulatory Framework
15. Demand And Supply-side Analysis
16. Value Chain Analysis
17. Competitive Scenario
18. Company Profiled
19. Disclaimer
Analyzing the historical market, estimation of the current market, and forecasting the future market of the global anxiety and depression treatment market were the three major steps undertaken to create and analyze the adoption of anxiety and depression treatment in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global anxiety and depression treatment market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments the industry pertains to. Detailed methodology is explained below:
Seek More Details About Research Methodology
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the anxiety and depression treatment through company internal sources such as annual report & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the anxiety and depression treatment market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments included in the report as drug type, disorder type, and distribution channel. Further country-level analyses were conducted to evaluate the overall adoption of Anxiety and Depression Treatment across the globe.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the anxiety and depression treatment. Further, we conducted factor analysis using dependent and independent variables such as the growing number of people with chronic diseases and the increasing elderly population all over the globe. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, merger and acquisition, business expansion, and product launches in the anxiety and depression treatment sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the anxiety and depression treatment market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., top-down/bottom-up approach was applied to arrive at the market forecast about 2027 for different segments and subsegments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
Data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers of each segment and sub-segment of the anxiety and depression treatment market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of drug type, disorder type, and distribution channel of the anxiety and depression treatment market.
The main objective of the Anxiety and Depression Treatment Market Study
The current & future market trends of anxiety and depression treatment were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit as a first-mover advantage. Other quantitative goals of the studies include:
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
